What is the IPHA stock price prediction for next 2 weeks?

According to our price prediction algorithm,Innate Pharma S.A. (IPHA) price will be around $1.66 in the next 2 weeks. This means it will decrease by -4.3965517241379315 from the last closing price. This prediction may vary from other time period filters for IPHA stock.

What can be the highest Possible price of IPHA stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, IPHA can achieve the highest price of $1.78 which is 2.082002283251436 higher than last closing price. This prediction may vary from other time period filters for IPHA stock.

What can be the lowest Possible price of IPHA stock in next 2 weeks?

As per the forecast and algorithmic analysis, IPHA stock price can be as low as $1.56 which is -10.30925884920929 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for IPHA stock.

Will IPHA stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that IPHA stock will lose-4.3965517241379315 in the next 2 weeks. This prediction may vary from other time period filters for IPHA stock.

What is IPHA stock last closing price?

Last closing price of IPHA stock was $1.75.

What is IPHA stock price prediction?

IPHA stock price prediction means predicting the future closing prices of IPHA stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of IPHA stock in a certain time period.

How we predict IPHA stock future prices?

If you are searching for IPHA stock forecast, analysis or price prediction, then you might be wondering what Innate Pharma S.A. (IPHA) will do in the future. Our IPHA price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This IPHA price prediction will likely answer most of your questions.

How frequent we update IPHA stock predictions?

We are updating the forecasts for the IPHA stock on daily basis.

Is using ML forecasting for IPHA stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for IPHA stock same for all the time periods?

No, the prediction for IPHA stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Innate Pharma S.A. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.75-3.31%Since 2 Weeks

Predicted Price$1.66-4.4%For 2 Weeks

Upper Predicted Price$1.782.08%For 2 Weeks

Lower Predicted Price$1.56-10.31%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of IPHA will decline by -4.40% over the next 2 Weeks and hit $1.66 by Tuesday, January 13, 2026. In that time frame, IPHA's share price is expected to range between $1.56 and $1.78.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 13, 2026	1.56	1.66	1.78
Jan 12, 2026	1.59	1.70	1.81
Jan 9, 2026	1.53	1.63	1.74
Jan 8, 2026	1.54	1.64	1.75
Jan 7, 2026	1.54	1.65	1.76
Jan 6, 2026	1.58	1.68	1.79
Jan 5, 2026	1.62	1.72	1.83
Jan 2, 2026	1.54	1.65	1.76
Jan 1, 2026	1.55	1.66	1.76
Dec 31, 2025	1.56	1.67	1.77

IPHA shares rose +0.57% in Wednesday, December 31, 2025's trading session, rising from a previous close of $1.74 to move at $1.75. The stock demonstrated notable intraday movement (see IPHA's key stats for a full breakdown), fluctuating between $1.70 and $1.80, a +5.88% trading range. While recent weeks have seen some volatility, IPHA has managed to secure a -5.91% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 15.35K shares changing hands, 17.95K fewer than the previous session. This amounted to $26.86K in total market activity.

Will IPHA Continue Its Upward Trend?

According to analyst ratings and projections for IPHA, Innate Pharma S.A. shares are anticipated to increase by +1.48%, potentially reaching $1.78 per share by January 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for IPHA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the IPHA stock forecast, now is a good time to buy IPHA stock because its current trading price is +5.20% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on IPHA covering social and institutional perspectives.

IPHA Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into IPHA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.07% to 43.80%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.35%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.92%, maintains a neutral outlook for the long term. Insights into IPHA's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Innate Pharma SA Short-Term Forecasts

IPHA Forecast For Next 5 Days

Our algorithm anticipates Innate Pharma SA (IPHA) stock could hit $1.69 by Jan 07, 2026. This represents a -3.52% fall from today's price, following a -0.57% change over the past five days.

IPHA Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Innate Pharma S.A. (IPHA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.65, which would mean a -5.71% decrease from the current price of $1.75. Projections for this period range from a high of $1.91 to a low of $1.42.

IPHA Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Innate Pharma SA's price over the next three months point to a rise. IPHA stock is expected to peak at $10.72 on Jan 02, 2026 before potentially dipping to $6.38 on Mar 31, 2026. On average, IPHA is likely to trade around $8.02 in the coming 90 days.

Innate Pharma SA Stock Forecast 2025

Based on our predictive models, Innate Pharma SA (IPHA) is expected to trade between $10.59 and $10.69 throughout 2025. This would result in an average price of $10.64, potentially offering investors a +508.00% return from current levels.

Innate Pharma S.A. Monthly Forecast 2025–2026

December 2025

According to our latest forecast models, Innate Pharma S.A. (IPHA) is positioned to show a strong performance in December 2025. The price is predicted to move between $10.59 and $10.69, settling at an average of $10.64. This could translate to a +508.00% gain.

January 2026

Based on current market signals, Innate Pharma S.A. is projected to trend january 2026. We forecast a trading range from $7.68 to $10.72, with a likely average price of $9.41. Investors could expect a potential return of +437.71%.

February 2026

Our predictive algorithms indicate Innate Pharma S.A. stock may see a shift in February 2026. The expected range spans $6.45–$7.79, with an average target of $7.00. This represents a positive outlook and a possible gain of +300.00%.

March 2026

Analyzing established trends, Innate Pharma S.A. looks set to move in March 2026. Projections place the stock between $6.38 and $7.94, averaging around $7.45. This suggests a +325.71% gain from current levels.

April 2026

Market indicators suggest Innate Pharma S.A. could experience notable changes during April 2026. Prices could fluctuate within $5.18 to $6.60, with a midpoint forecast of $5.94. The stock might deliver a +239.43% gain.

May 2026

Forecasting for May 2026, models estimate that Innate Pharma S.A. may undergo key fluctuations. If trends hold, the stock might trade between $5.78 and $7.97, averaging $6.92. This signals a positive trajectory with potential returns around +295.43%.

June 2026

According to our latest forecast models, Innate Pharma S.A. (IPHA) is positioned to show a strong performance in June 2026. The price is predicted to move between $3.77 and $7.87, settling at an average of $6.08. This could translate to a +247.43% gain.

July 2026

Based on current market signals, Innate Pharma S.A. is projected to trend july 2026. We forecast a trading range from $3.05 to $6.72, with a likely average price of $4.71. Investors could expect a potential return of +169.14%.

August 2026

Our predictive algorithms indicate Innate Pharma S.A. stock may see a shift in August 2026. The expected range spans $4.24–$7.18, with an average target of $6.34. This represents a positive outlook and a possible gain of +262.29%.

September 2026

Analyzing established trends, Innate Pharma S.A. looks set to move in September 2026. Projections place the stock between $3.39 and $6.98, averaging around $5.75. This suggests a +228.57% gain from current levels.

October 2026

Market indicators suggest Innate Pharma S.A. could experience notable changes during October 2026. Prices could fluctuate within $3.39 to $8.08, with a midpoint forecast of $6.35. The stock might deliver a +262.86% gain.

November 2026

Forecasting for November 2026, models estimate that Innate Pharma S.A. may undergo key fluctuations. If trends hold, the stock might trade between $1.71 and $7.65, averaging $5.33. This signals a positive trajectory with potential returns around +204.57%.

December 2026

According to our latest forecast models, Innate Pharma S.A. (IPHA) is positioned to show a strong performance in December 2026. The price is predicted to move between $1.57 and $9.05, settling at an average of $5.23. This could translate to a +198.86% gain.

IPHA's history of dividends and stock splits also plays a role in long-term investor confidence.